PMC2018 Mobile Header 300x76

Lipid Targets-How Low Do We Go

Type: Keynote
Therapeutic: Cardiovascular Medicine,Diabetes, & Metabolism,Endocrinology,Screening & Prevention
Friday May 11
8:30am to 9:30am
Location: Lecture Hall 1
Credits: 1 Mainpro+

  • Description

    This presentation aims to provide a cutting edge and contemporary discussion about the role of LDL-C in the pathophysiology of atherosclerosis and associated complications. Recent data from large randomized trials will be presented, and the clinical implications of these data in patients at risk of cardiovascular disease will be emphasized. Guideline updates will also be discussed and practical guidance on achieving LDL-C targets provided.

    Learning Objectives
    • To discuss the evidence of LDL-C in the context of primary and secondary prevention of atherosclerotic cardiovascular disease.
    • To evaluate the recent clinical trial evidence with lipid lowering approaches in secondary prevention.
    • To discuss the current clinical practice guidelines in dyslipidemia and provide practical advice.

  • Speakers